Form 8-K - Current report:
SEC Accession No. 0001437749-20-005682
Filing Date
2020-03-19
Accepted
2020-03-19 16:04:33
Documents
5
Period of Report
2020-03-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20200318_8k.htm 8-K 31360
2 EXHIBIT 99.1 ex_178108.htm EX-99.1 159083
3 EXHIBIT 99.2 ex_178061.htm EX-99.2 12244
4 ex_178053img001.jpg GRAPHIC 4264
5 ex_178108img001.jpg GRAPHIC 4264
  Complete submission text file 0001437749-20-005682.txt   216169
Mailing Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 20728448
SIC: 2836 Biological Products, (No Diagnostic Substances)